This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...